1,5-Dihydroxyxanthone

Details

Top
Internal ID 0b9fb4c7-c19d-444d-b533-b809cca2e596
Taxonomy Organoheterocyclic compounds > Benzopyrans > 1-benzopyrans > Xanthones
IUPAC Name 1,5-dihydroxyxanthen-9-one
SMILES (Canonical) C1=CC2=C(C(=C1)O)OC3=CC=CC(=C3C2=O)O
SMILES (Isomeric) C1=CC2=C(C(=C1)O)OC3=CC=CC(=C3C2=O)O
InChI InChI=1S/C13H8O4/c14-8-4-2-6-10-11(8)12(16)7-3-1-5-9(15)13(7)17-10/h1-6,14-15H
InChI Key APIPFXZYOMIJQG-UHFFFAOYSA-N
Popularity 40 references in papers

Physical and Chemical Properties

Top
Molecular Formula C13H8O4
Molecular Weight 228.20 g/mol
Exact Mass 228.04225873 g/mol
Topological Polar Surface Area (TPSA) 66.80 Ų
XlogP 2.80
Atomic LogP (AlogP) 2.36
H-Bond Acceptor 4
H-Bond Donor 2
Rotatable Bonds 0

Synonyms

Top
14686-65-8
1,5-dihydroxyxanthen-9-one
1,5-DIHYDROXY-9H-XANTHEN-9-ONE
9H-Xanthen-9-one, 1,5-dihydroxy-
CHEMBL185686
1,5-Dihydroxy-xanthen-9-one
SCHEMBL15527312
DTXSID80420489
BDBM50155419
1,5-Dihydroxy-9H-xanthen-9-one, 9CI

2D Structure

Top
2D Structure of 1,5-Dihydroxyxanthone

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9717 97.17%
Caco-2 - 0.7016 70.16%
Blood Brain Barrier - 0.8250 82.50%
Human oral bioavailability + 0.7429 74.29%
Subcellular localzation Mitochondria 0.6458 64.58%
OATP2B1 inhibitior - 0.6993 69.93%
OATP1B1 inhibitior + 0.9352 93.52%
OATP1B3 inhibitior + 0.9836 98.36%
MATE1 inhibitior - 0.5200 52.00%
OCT2 inhibitior - 0.9750 97.50%
BSEP inhibitior - 0.7675 76.75%
P-glycoprotein inhibitior - 0.8465 84.65%
P-glycoprotein substrate - 0.9430 94.30%
CYP3A4 substrate - 0.5607 56.07%
CYP2C9 substrate - 0.6265 62.65%
CYP2D6 substrate - 0.8495 84.95%
CYP3A4 inhibition + 0.5297 52.97%
CYP2C9 inhibition + 0.5447 54.47%
CYP2C19 inhibition - 0.6827 68.27%
CYP2D6 inhibition - 0.9006 90.06%
CYP1A2 inhibition + 0.9448 94.48%
CYP2C8 inhibition - 0.8591 85.91%
CYP inhibitory promiscuity - 0.6121 61.21%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 0.9700 97.00%
Carcinogenicity (trinary) Non-required 0.5084 50.84%
Eye corrosion - 0.9693 96.93%
Eye irritation + 0.9733 97.33%
Skin irritation + 0.6448 64.48%
Skin corrosion - 0.9838 98.38%
Ames mutagenesis + 0.7000 70.00%
Human Ether-a-go-go-Related Gene inhibition - 0.9088 90.88%
Micronuclear + 0.8300 83.00%
Hepatotoxicity + 0.6375 63.75%
skin sensitisation - 0.8100 81.00%
Respiratory toxicity + 0.5889 58.89%
Reproductive toxicity + 0.6444 64.44%
Mitochondrial toxicity - 0.5250 52.50%
Nephrotoxicity - 0.5841 58.41%
Acute Oral Toxicity (c) III 0.6516 65.16%
Estrogen receptor binding + 0.7657 76.57%
Androgen receptor binding - 0.5275 52.75%
Thyroid receptor binding + 0.6547 65.47%
Glucocorticoid receptor binding + 0.9038 90.38%
Aromatase binding + 0.8598 85.98%
PPAR gamma + 0.8916 89.16%
Honey bee toxicity - 0.9389 93.89%
Biodegradation - 0.7750 77.50%
Crustacea aquatic toxicity - 0.6000 60.00%
Fish aquatic toxicity + 0.7742 77.42%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
CHEMBL1951 P21397 Monoamine oxidase A 730 nM
IC50
PMID: 15482934

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 95.51% 95.56%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 95.18% 91.11%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 93.47% 99.23%
CHEMBL1806 P11388 DNA topoisomerase II alpha 93.13% 89.00%
CHEMBL2581 P07339 Cathepsin D 89.98% 98.95%
CHEMBL3192 Q9BY41 Histone deacetylase 8 89.84% 93.99%
CHEMBL3401 O75469 Pregnane X receptor 89.08% 94.73%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 85.27% 94.00%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 84.14% 94.45%
CHEMBL3959 P16083 Quinone reductase 2 81.76% 89.49%
CHEMBL2535 P11166 Glucose transporter 80.23% 98.75%

Cross-Links

Top
PubChem 5480299
NPASS NPC59551
ChEMBL CHEMBL185686
LOTUS LTS0052188
wikiData Q82231778